Clinical Trial Update: Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial assesses safety, tolerability, and pharmacokinetic parameters of inhaled sodium nitrite solution in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Sodium nitrite inhalation solution (sodium nitrite inhalation solution)

Snippet

Sponsor: Aires Pharmaceuticals, Inc. | Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED